The importance of PR signaling in mutant Brca1 tumorigenesis was further demonstrated by Poole et al. 3 who showed that tumor development in Brca1/p53 deficient mice could be prevented by the PR antagonist RU-486. The gene discussed is BRCA1; the disease is neoplasm.